BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 10443963)

  • 1. Antiphospholipid syndrome and thrombosis.
    Bick RL; Baker WF
    Semin Thromb Hemost; 1999; 25(3):333-50. PubMed ID: 10443963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antiphospholipid and thrombosis (APL-T) syndromes. Clinical and laboratory correlates.
    Bick RL; Ancypa D
    Clin Lab Med; 1995 Mar; 15(1):63-84. PubMed ID: 7781279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid and thrombosis syndromes.
    Bick RL; Baker WF
    Semin Thromb Hemost; 1994; 20(1):3-15. PubMed ID: 8059232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphospholipid thrombosis syndromes.
    Bick RL
    Clin Appl Thromb Hemost; 2001 Oct; 7(4):241-58. PubMed ID: 11697705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid thrombosis syndromes.
    Bick RL
    Hematol Oncol Clin North Am; 2003 Feb; 17(1):115-47. PubMed ID: 12627666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticardiolipin antibodies and thrombosis.
    Bick RL; Baker WF
    Hematol Oncol Clin North Am; 1992 Dec; 6(6):1287-99. PubMed ID: 1452512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiphospholipid and thrombosis syndromes.
    Bick RL; Baker WF
    Med Clin North Am; 1994 May; 78(3):667-84. PubMed ID: 8170264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid-thrombosis syndromes.
    Bick RL; Arun B; Frenkel EP
    Haemostasis; 1999; 29(2-3):100-10. PubMed ID: 10629391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiphospholipid-thrombosis syndromes. Fact, fiction, confusion, and controversy.
    Bick RL
    Am J Clin Pathol; 1993 Nov; 100(5):477-80. PubMed ID: 8249884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiphospholipid syndrome: when does the presence of antiphospholipid antibodies require therapy?
    Devine DV; Brigden ML
    Postgrad Med; 1996 Jun; 99(6):105-8, 113-25. PubMed ID: 8668625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative analysis of clinical and laboratory charactiristics of antiphospholipid syndrome].
    Soltész P; Veres K; Kiss E; Lakos G; Sonkoly I; Muszbek L; Szegedi G
    Orv Hetil; 2000 Dec; 141(52):2821-5. PubMed ID: 11202118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid syndrome.
    Gezer S
    Dis Mon; 2003 Dec; 49(12):696-741. PubMed ID: 14679358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
    Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M
    Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thrombosis in the antiphospholipid syndrome.
    Farmer-Boatwright MK; Roubey RA
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):321-5. PubMed ID: 19228605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies, haemostatic variables and thrombosis--a survey of 144 patients.
    Ames PR; Pyke S; Iannaccone L; Brancaccio V
    Thromb Haemost; 1995 May; 73(5):768-73. PubMed ID: 7482401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiphospholipid thrombosis syndrome and acquired activated protein C resistance].
    Wu J; Zhou Z; Li X; Li X; Chen Y; Wang G; Xu X; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2000 Mar; 21(3):122-4. PubMed ID: 11876968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of thrombosis in secondary antiphospholipid-protein syndrome].
    Swadźba J; Musiał J; Jankowski M; Grzywacz M; Szczeklik A
    Pol Merkur Lekarski; 1996 Nov; 1(5):310-2. PubMed ID: 9273202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.